The treatment of EPTB in children involves a prolonged course of anti-tuberculous therapy (ATT), usually consisting of multiple drugs to prevent the development of drug resistance. The standard regimen includes:
- Intensive Phase: Generally 2 months of isoniazid, rifampin, pyrazinamide, and ethambutol. - Continuation Phase: Followed by 4-7 months of isoniazid and rifampin.
The duration of treatment may vary based on the form and severity of EPTB. Corticosteroids may be used as adjunctive therapy in certain forms, such as tuberculous meningitis and pericarditis, to reduce inflammation and complications.
